NeuroOne Medical Technologies
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NeuroOne Medical Technologies
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
Frequently asked questions
To buy NeuroOne Medical Technologies stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NeuroOne Medical Technologies by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NeuroOne Medical Technologies is NMTC:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NeuroOne Medical Technologies has its primary listing on NASDAQ (Small cap). You can trade NeuroOne Medical Technologies with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NeuroOne Medical Technologies is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include NeuroOne Medical Technologies as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like NeuroOne Medical Technologies .